The RAS/RAF/MAPK/ERK and PI3K/AKT pathways are considered the two most common cascade signaling pathways involved in bypass activation, and mutations or amplifications in key genes in these two pathways can mediate NSCLC TKI resistance (31, 32, 34, 152). Here, AKT1 is linked to non-small cell lung carcinoma.